000 01160 a2200289 4500
005 20250517004432.0
264 0 _c20150729
008 201507s 0 0 eng d
022 _a1532-1924
024 7 _a10.1016/j.beha.2014.10.014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrupp, Stephan A
245 0 0 _aAdvances in T-cell therapy for ALL.
_h[electronic resource]
260 _bBest practice & research. Clinical haematology
_c
300 _a222-8 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntibodies, Monoclonal, Humanized
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aInterleukin-6
_xantagonists & inhibitors
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xgenetics
650 0 4 _aReceptors, Antigen, T-Cell
650 0 4 _aT-Lymphocytes
_ximmunology
773 0 _tBest practice & research. Clinical haematology
_gvol. 27
_gno. 3-4
_gp. 222-8
856 4 0 _uhttps://doi.org/10.1016/j.beha.2014.10.014
_zAvailable from publisher's website
999 _c24409658
_d24409658